Properties of [3H]bunazosin binding in rat kidney

T. Ogura, E. Katayama, T. Mitsui, K. Takatori, Z. Ota, K. Mizukawa, N. Ogawa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Properties of alpha1-adrenoceptor binding in the renal cortex of rats were studied with [3H]bunazosin as the radiolabeled ligand. Both temperature and incubation time influened bunazosin receptor binding. Subcellular distribution of [3H]bunazosin binding revealed that the membrane fraction (30,000 x g pellet) had the largest proportion of total binding sites. Pretreatment of membrane preparation at 56°C for 30 minutes greatly decreased the specific binding of [3H]bunazosin, though there was no significant effect of the pretreatment at 24°C and 37°C for 30 minutes. Among various cations, some divalent ions such as Cu++ and Zn++ greatly decreased bunazosin binding, whereas monovalent ions had no effect on specific binding. Results of Scatchard analysis suggested that the rat renal cortex membrane has single binding sites with an apparent dissociation constant of 0.38 ± 0.06 nmol/L, though the rat medulla membrane has no potent binding activity with bunazosin. The displacement study revealed that various adrenergic agents inhibit [3H]bunazosin binding in dose-dependent fashion; the rank order of potencies was bunazosin prazosin > phentolamine >> dl-norepinephrine > clonidine, yohimbine >> pindolol, propranolol. These findings reveal that bunazosin has specific receptor binding in the rat renal cortex, indicating that alpha1-adrenoceptors exist in the rat renal cortex.

Original languageEnglish
Pages (from-to)559-567
Number of pages9
JournalClinical Therapeutics
Volume10
Issue number5
Publication statusPublished - 1988

Fingerprint

Kidney
Membranes
Adrenergic Receptors
Binding Sites
Ions
Pindolol
bunazosin
Yohimbine
Prazosin
Phentolamine
Divalent Cations
Clonidine
Propranolol
Adrenergic Agents
Norepinephrine
Ligands
Temperature

ASJC Scopus subject areas

  • Pharmacology

Cite this

Ogura, T., Katayama, E., Mitsui, T., Takatori, K., Ota, Z., Mizukawa, K., & Ogawa, N. (1988). Properties of [3H]bunazosin binding in rat kidney. Clinical Therapeutics, 10(5), 559-567.

Properties of [3H]bunazosin binding in rat kidney. / Ogura, T.; Katayama, E.; Mitsui, T.; Takatori, K.; Ota, Z.; Mizukawa, K.; Ogawa, N.

In: Clinical Therapeutics, Vol. 10, No. 5, 1988, p. 559-567.

Research output: Contribution to journalArticle

Ogura, T, Katayama, E, Mitsui, T, Takatori, K, Ota, Z, Mizukawa, K & Ogawa, N 1988, 'Properties of [3H]bunazosin binding in rat kidney', Clinical Therapeutics, vol. 10, no. 5, pp. 559-567.
Ogura T, Katayama E, Mitsui T, Takatori K, Ota Z, Mizukawa K et al. Properties of [3H]bunazosin binding in rat kidney. Clinical Therapeutics. 1988;10(5):559-567.
Ogura, T. ; Katayama, E. ; Mitsui, T. ; Takatori, K. ; Ota, Z. ; Mizukawa, K. ; Ogawa, N. / Properties of [3H]bunazosin binding in rat kidney. In: Clinical Therapeutics. 1988 ; Vol. 10, No. 5. pp. 559-567.
@article{61ed496a308d4f3e95f09db0c9ff4537,
title = "Properties of [3H]bunazosin binding in rat kidney",
abstract = "Properties of alpha1-adrenoceptor binding in the renal cortex of rats were studied with [3H]bunazosin as the radiolabeled ligand. Both temperature and incubation time influened bunazosin receptor binding. Subcellular distribution of [3H]bunazosin binding revealed that the membrane fraction (30,000 x g pellet) had the largest proportion of total binding sites. Pretreatment of membrane preparation at 56°C for 30 minutes greatly decreased the specific binding of [3H]bunazosin, though there was no significant effect of the pretreatment at 24°C and 37°C for 30 minutes. Among various cations, some divalent ions such as Cu++ and Zn++ greatly decreased bunazosin binding, whereas monovalent ions had no effect on specific binding. Results of Scatchard analysis suggested that the rat renal cortex membrane has single binding sites with an apparent dissociation constant of 0.38 ± 0.06 nmol/L, though the rat medulla membrane has no potent binding activity with bunazosin. The displacement study revealed that various adrenergic agents inhibit [3H]bunazosin binding in dose-dependent fashion; the rank order of potencies was bunazosin prazosin > phentolamine >> dl-norepinephrine > clonidine, yohimbine >> pindolol, propranolol. These findings reveal that bunazosin has specific receptor binding in the rat renal cortex, indicating that alpha1-adrenoceptors exist in the rat renal cortex.",
author = "T. Ogura and E. Katayama and T. Mitsui and K. Takatori and Z. Ota and K. Mizukawa and N. Ogawa",
year = "1988",
language = "English",
volume = "10",
pages = "559--567",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "5",

}

TY - JOUR

T1 - Properties of [3H]bunazosin binding in rat kidney

AU - Ogura, T.

AU - Katayama, E.

AU - Mitsui, T.

AU - Takatori, K.

AU - Ota, Z.

AU - Mizukawa, K.

AU - Ogawa, N.

PY - 1988

Y1 - 1988

N2 - Properties of alpha1-adrenoceptor binding in the renal cortex of rats were studied with [3H]bunazosin as the radiolabeled ligand. Both temperature and incubation time influened bunazosin receptor binding. Subcellular distribution of [3H]bunazosin binding revealed that the membrane fraction (30,000 x g pellet) had the largest proportion of total binding sites. Pretreatment of membrane preparation at 56°C for 30 minutes greatly decreased the specific binding of [3H]bunazosin, though there was no significant effect of the pretreatment at 24°C and 37°C for 30 minutes. Among various cations, some divalent ions such as Cu++ and Zn++ greatly decreased bunazosin binding, whereas monovalent ions had no effect on specific binding. Results of Scatchard analysis suggested that the rat renal cortex membrane has single binding sites with an apparent dissociation constant of 0.38 ± 0.06 nmol/L, though the rat medulla membrane has no potent binding activity with bunazosin. The displacement study revealed that various adrenergic agents inhibit [3H]bunazosin binding in dose-dependent fashion; the rank order of potencies was bunazosin prazosin > phentolamine >> dl-norepinephrine > clonidine, yohimbine >> pindolol, propranolol. These findings reveal that bunazosin has specific receptor binding in the rat renal cortex, indicating that alpha1-adrenoceptors exist in the rat renal cortex.

AB - Properties of alpha1-adrenoceptor binding in the renal cortex of rats were studied with [3H]bunazosin as the radiolabeled ligand. Both temperature and incubation time influened bunazosin receptor binding. Subcellular distribution of [3H]bunazosin binding revealed that the membrane fraction (30,000 x g pellet) had the largest proportion of total binding sites. Pretreatment of membrane preparation at 56°C for 30 minutes greatly decreased the specific binding of [3H]bunazosin, though there was no significant effect of the pretreatment at 24°C and 37°C for 30 minutes. Among various cations, some divalent ions such as Cu++ and Zn++ greatly decreased bunazosin binding, whereas monovalent ions had no effect on specific binding. Results of Scatchard analysis suggested that the rat renal cortex membrane has single binding sites with an apparent dissociation constant of 0.38 ± 0.06 nmol/L, though the rat medulla membrane has no potent binding activity with bunazosin. The displacement study revealed that various adrenergic agents inhibit [3H]bunazosin binding in dose-dependent fashion; the rank order of potencies was bunazosin prazosin > phentolamine >> dl-norepinephrine > clonidine, yohimbine >> pindolol, propranolol. These findings reveal that bunazosin has specific receptor binding in the rat renal cortex, indicating that alpha1-adrenoceptors exist in the rat renal cortex.

UR - http://www.scopus.com/inward/record.url?scp=0023822155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023822155&partnerID=8YFLogxK

M3 - Article

C2 - 2908804

AN - SCOPUS:0023822155

VL - 10

SP - 559

EP - 567

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 5

ER -